Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS) SHH
47.31
+0.63(+1.35%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
47.31
+0.63(+1.35%)
Currency In CNY
| Market Cap | 10.7B |
| Enterprise Value | 10.03B |
| P/E Ratio | 30.16 |
| PEG Ratio | 1.24 |
| Price/Sales Ratio | 6.18 |
| Price/Book Ratio | 2.76 |
| Enterprise/Revenue | 6.02 |
| Enterprise/EBITDA | 24.84 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.2 |
| Operating Margin | 0.21 |
| Return On Assets | 0.07 |
| Return On Equity | 0.1 |
| Revenue | 1.33B |
| Revenue/Share | 7.75 |
| Gross Profit | 1.33B |
| EBITDA | 380.75M |
| Net Income | 283.25M |
| Diluted EPS | 1.63 |
| Total Cash | 1.62B |
| Total Cash/Share | 9.3 |
| Total Debt | 115.68M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 3.82 |
| Book Value Per Share | 17.7 |
| 52-Week Change | 9.92 |
| 52-Week High | 80.48 |
| 52-Week Low | 37.5 |
| Moving Average 50 Days | 62.82 |
| Moving Average 200 Days | 59.52 |
| Average Volume | 2.74M |
| Shares Outstanding | 176.53M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.49 |
| Trailing Annual Dividend Yield | 1.04 |
| Payout Ratio | 0.28 |
| Last Split Factor | 147:100 |
| Last Split Date | July 01, 2024 |